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Summary.-The inhibition of cell growth, the reduction of cell survival and the
induction of chromosome aberrations and of sister chromatid exchange (SCE) have
been determined in cultured hamster cell lines (BHK and CHO) treated with 11
water-soluble compounds of hexavalent and trivalent chromium.
All Cr6+ compounds inhibit growth of BHK cells and reduce survival of CHO cells
to levels comparable to those obtained only after exposure to 100-1000 times higher
Cr3+ concentrations. The cytotoxicity curves obtained with the different Cr6+ com-
pounds are almost overlapping, whereas marked differences of activity are noticeable
among Cr3+ compounds. Giant cells are obtained after exposure to Cr6+ and Cr3+
compounds, as shown by the rise of DNA and RNA per cell, and are due to the block-
age of the cell cycle without sudden inhibition of macromolecular syntheses.
Both Cr6+ and Cr3+ compounds are ableto induce chromosome aberrations, whereas
Cr3+ is absolutely incapable of inducing SCE, only Cr6+ being active. The frequency of
chromosome aberrations is increased about 10-fold after exposure to 1-0 jug/ml Cr6+,
whereas it is only doubled after treatment with up to 150 jug/ml Cr3+. On the other
hand, in spite of the sensitivity of CHO cells to the induction of SCE by mitomycin C,
the frequency of SCE hardly doubles after exposure to Cr6+ compounds.
The present data confirm that Cr6+ compounds are characterized by a marked
cytotoxicity and clastogenic action on mammalian cell cultures and show that Cr3+
compounds, though cytotoxic only at extremely high concentrations and not increas-
ing the frequency of SCE, are not completely without cytogenetic effect, as they are
able to induce chromosome aberrations.
A COMPARISON of the cytotoxic and
cytogenetic effects of Cr6+ (as potassium
dichromate) and Cr3+ (as chromium chlor-
ide) on mammalian cell cultures was
carried out in our laboratory, and showed
quite different mechanisms of action, on
the basis of their effects on the physico-
chemical properties of nucleic acids
(Tamino, 1977), the uptake of nucleosides
and nucleic acid synthesis (Levis et al.,
1978a, b; Bianchi et al., 1979), the mitotic
cycle (Majone, 1977) and the frequencies
of chromosome aberrations and sister
chromatid exchanges (Majone & Levis,
1979; Majone & Rensi, 1979). The study
of the cytotoxic and clastogenic action of
chromium on mammalian cells grown in
vitro has been extended here to 11 water-
soluble compounds of Cr6+ and Cr3+.
MATERIALS AND METHODS
Cells.-Cultures of the established pseudo-
diploid BHK21 Syrian hamster fibroblast
line, and of the established pseudodiploid
CHO Chinese hamster ovary fibroblast line
were grown at 37°C as monolayers, in Eagle's
minimal essential medium supplemented with
10% calf serum. Cultures in glass Petri dishes
were maintained in a humidified 5% C02
atmosphere. 025% trypsin (Difco 1:250,
Detroit, Mich., U.S.A.) was routinely used for
subculturing. The cultures were periodically
tested for the presence of Mycoplasma by
Dr L. Conventi (Institute of Microbiology,
University of Padua) with standard selective
culture media (Barile, 1973).
Cell growth and labelling.-To determine the
cytotoxic action of Cr on cell growth, 105
BHK cells from log-phase cultures were
seeded in 60mm Petri dishes and treated asA. G. LEVIS AND F. MAJONE
specified in the Results section. Cell growth
was estimated on the basis of the nucleic-acid
content (RNA+DNA) of each culture, deter-
mined 5 days after seeding, when controls
became confluent. To this purpose nucleotides
and nucleic acids were sequentially extracted
by differential hydrolyses with perchloric
acid (PCA): soluble nucleotides of the
intracellular pool were extracted with 5%
PCA at 4°C for 30 min, RNA was hydrolysed
with 10%/ PCA at 37°C for 1 h, and DNA was
hydrolysed with 10% PCA at 70°C for 2 h.
Soluble nucleotides and RNA were measured
by UV absorption at 260 nm, DNA was
measured at 268 nm, with a Hitachi 200-20
double-beam spectrophotometer. In order to
label nucleic acids, the cultures were incu-
bated with tritiated nucleosides (Radio-
chemical Centre, Amersham, England): thy-
midine-6-H3 ([3H]-TdR; 2 Ci/mM) and
uridine-5-H3 ([3H]-UR; 2-5 Ci/mM) were
used at the concentration of 2 ,uCi/ml. After
labelling, nucleotides and nucleic acids were
extracted and determined as above, and the
radioactivity of liquid samples (0-5 ml) of
the different fractions was counted in a
Packard Tri-Carb 2425 scintillation counter,
using 10 ml of Bray's solution. As stated else-
where (Levis et al., 1978a, b) the extraction
procedure with PCA allows both quantitative
determinations and radioactivity counting
of different fractions (soluble nucleotides,
RNA and DNA) obtained from the same
culture.
Cell survival.-To determine the effects of
Cr on cell survival, CHO cells were harvested
from log-phase cultures, and samples of
single-cell suspensions, properly diluted with
growth medium, were plated in 60mm Petri
dishes directly in the presence of Cr. The
medium was not changed until the 8th day,
when the plates were stained with acetic
gentian violet, and scored for survivors. All
colonies visible to the naked eye were counted
as survivors.
Chromosome preparations.-Suspensions of
CHO cells were prepared by trypsinization of
log-phase cultures and diluted with growth
medium in 100mm Petri plates. Each plate
received about 8 x 105 cells in 10 ml of
medium, which was changed24hafterseeding.
At this time 3 x 10-5 M bromodeoxyuridine
(BUdR, Sigma, St Louis, Mo., U.S.A.) was
added and the cells were allowed to incor-
porate the analogue for two division cycles
(30 h). Crcompounds (seebelow) ormitomycin
C (Sigma) were added at the same time as
BUdR. The medium was not changed until
the cells were collected 30 h later. During the
last 4 h of treatment, 0 4 Hg/ml of colchicine
(Merck, Darmstadt, Germany) were added. At
the end of treatment, metaphase cells were
dislodged by gently pipetting the overlaying
medium and collected by centrifuging the
suspension at 900 rev/min for 5 min. The cell
pellet was suspended in 5 ml hypotonic buffer
(10% sodium citrate) at 37°C for 10 min and
fixed in ethanol/acetic acid (3/1). Fixed cells
were heated at 89°C for 10 min in IM
NaH2PO4 (pH 8) and stained with Giemsa
(Korenberg & Freedlender, 1974). All cultures
were treated with BUdR so that sister
chromatid exchanges (SCE) and chromosome
aberrations were scored on the same cell
preparations: 1st and 2nd division meta-
phases could be distinguished because bifilarly
BUdR-substituted chromatids stain paler
with Giemsa.
Chromium compounds and cell treatments.-
Hexavalent chromium (Cr6+) was tested as
K2Cr207 (potassium dichromate), K2CrO4
(potassium chromate) and Na2CrO4.4H20
(sodium chromate) (Mallinckrodt, St Louis,
Mo., U.S.A.), as Na2Cr2O7.2H20 (sodium
dichromate) (Riedel De Haen, Hannover,
Germany), as CrO3 (chromic acid) (Merck,
Darmstadt, Germany), and as CaCrO4 (cal-
cium chromate) (BDH, Poole, England).
Trivalent chromium (Cr3+) was tested as
CrCl3.6H20 (chromium chloride) and Cr-
(NO3)3.9H20 (chromium nitrate) (Merck),
as CrK(SO4)2.12H20 (chromium potassium
sulphate) and Cr(COOCH3)3 (chromium ace-
tate) (BDH), and as Cr(NO3)3.9H20 (chro-
mium nitrate) (Riedel De Haen). All chro-
mium compounds were analytical-grade re-
agents and were soluble in water at concentra-
tions up to 10-3M, except CaCrO4 and Cr
(COOCH3)3, which were soluble up to 10-3M
and 8x 10-3M respectively. Concentrated
solutions were made in twice-distilled water,
sterilized by filtration through 0-22,um porous
Millipore filters, and kept frozen at -30'C.
At the time of treatment Cr solutions were
diluted in prewarmed culture medium to the
final concentrations used for the experimental
treatments (see Results section).
Chromium determinations.-Oxidized Cr6+
was determined spectrophotometrically at
540 nm by the coloured reaction complex
with 1,5-diphenylcarbazide (DFCA, Riedel
De Haen) in H2SO4-acidified solutions (Taras
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et al., 1971). Total Cr was determined by the
same reaction after oxidation to Cr6+ with
potassium permanganate in acid medium
(Taras et al., 1971). Reduced Cr3+ was then
calculated by the difference between total
Cr and Cr6+ content. The colorimetric method
is sensitive to 0 01 jtg Cr6+/ml final solution,
with 5-cm spectrophotometric cells. Beer's
law is followed up to a concentration of 2 ,ug
Cr6+ per ml final solution (or 2 parts in 106),
as shown by the standard calibration curves.
RESULTS
1. Chromium content and oxidation state of
the tested compounds
Data on the cytotoxic and clastogenic
effects of the different tested compounds
have been referred to the actual Cr con-
tents determined by DFCA in the treat-
ment solutions. With regard to the oxida-
tion state of Cr, it was confirmed that all
Cr6+ compounds contain only oxidized
Cr. On the other hand Cr(NO3)3 produced
100
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by Riedel was shown to contain about 2
parts Cr6+ per 1000 parts Cr3+. This was
determined in different solutions prepared
from separate stocks never used before,
so that accidental contamination in the
laboratory canberuled out. Cr (NO3)3pro-
duced by Merck, and all other Cr3+ com-
pounds did not react directly with DFCA,
but only after oxidation with sodium
permanganate: as the colorimetric method
allows one to determine 0.01 ,ug/ml Cr6+
in solutions containing up to 1000 ,ug/ml
Cr3+ (see Methods section), contamination
with more than 1 part Cr6+ in 105 parts
Cr3+ is excluded.
2. Effects on celt growth
Fig. 1 shows the cytotoxic action on the
growth of BHK cell cultures of chronic
exposures to Cr6+ and Cr3+ compounds.
The cultures were treated starting from
the 24th h after seeding and nucleic acid
content was determined at the 5th day,
Chromium (pjg /ml)
FIG. 1.-Effects of Cr compounds on BHK cell growth. Treatments were initiated 24 h after seeding
and were continued to the 5th day, when cell growth was determined on the basis of nucleic acid
content ofeach culture. K2Cr2O7 (*); Na2Cr2O7 (0); K2CrO4 (A*); Na2CrO4 (A); CrO3 (*); CaCrO4
(O); CrCl3 (*); Riedel Cr (NO3)3 ( *); Merck Cr (NO3)3 ( *); CrK (SO4)3 ( *); Cr (COOCH3) (*).
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when controls became confluent. It can
be observed that the different Cr6+ com-
pounds have quite comparable cytotoxic
effects: the 50% inhibiting dose (ID50) is
about 0 5 pg/ml Cr6+. Cr3+ compounds are
cytotoxic only at much higher concentra-
tions, their ID50 being 50-150 ,ug/ml
Cr3+, but CrCl3 and Merck Cr(NO3)3 have
little or no cytotoxic action even at
300 tg/ml Cr3+, which is the maximum
solubility in complete growth medium.
Riedel Cr(NO )3whichis contaminated by
Cr6+, is more cytotoxic than Merck
nitrate, the ID50 being about 180 pg/ml
Cr6+. On the other hand chromium sul-
phate and acetate, though not containing
Cr6+, are weakly cytotoxic.
Data on growth inhibition have also
been obtained after acute treatments with
Cr6+ and Cr3+ compounds (Fig. 2): BHK
cell cultures were exposed only for 4 h,
starting from the 24th h after seeding, and
were reincubated with normal growth
medium up to the 5th day, when controls
100-
80-
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20-
became confluent. The toxicity curves
the different Cr6+ compounds are aga
very similar, the ID50 being 6-10 ,ug/r
Cr6+. On the other hand, in such treatmei
conditions all Cr3+ compounds are almo
inactive up to their maximum solub
concentrations.
3. Effects on cell survival
The effects of chronic exposure to Cr
and Cr3+ compounds on the survival
CHO cell cultures are shown in Fig.
Single-cell suspensions were seeded at lo
celldensities (150 cells/dish) inthepresen,
of Cr, so that treatment was initiat(
before the cells started to divide. Therefo
the inactivation of a single cell product
the loss of a "surviving" macroscop
colony. It can be noted that Cr6+ cor
pounds inactivate cell survival with qui
overlapping kinetics, whereas Cr3+ cor
pounds have only limited and more vari(
effects. The 50% lethal dose (LD50) f
Cr6+ is - 0 15 ,ug/ml, whereas it is aboi
9
1 2 5 10 20 50 100 300
Chromium (p9g/ml)
FIG. 2.-Effects of Cr compounds on BHK cell growth. Treatments lasted for 4 h, 24 h after seeding.
Cell growth was determined at the 5th day. Symbols for compounds as in Fig. 1.
* *
* **
* *
*
*
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FIG. 3.-Effects of Cr compounds on CHO cell survival. Single-cell suspensions were seeded in.the
presence of Cr and were treated up to the 8th day, when survival was measured as macroscopic
colonies. Symbols for compounds as in Fig. 1.
60 pg/ml Cr3+ for Riedel Cr(NO3)3 and
150 /tg/ml for chromium acetate, and it is
not definable for the other Cr3+ com-
pounds, owing to their very low toxicity
even at the maximum soluble concentra-
tions.
Cr6+ survival curves show multi-hit
inactivation kinetics, that is, an exponen-
tial portion preceded by a rather marked
shoulder (Fig. 4). If the straight portion
of the curve is extrapolated back to the
ordinate axis, the intersection occurs close
to 10 (not shown).
4. Giant-cell induction and effects on RNA
extractability
Microscopic examination of BHK and
CHO cell cultures exposed to Cr6+ revealed
that giant cells are induced. After treat-
ment with Cr6+ concentrations which
drasticallyreduce cellgrowth andsurvival,
almost pure populations of giant cells can
be obtained, both DNA and RNA per cell
being greatly increased (Table I). Such an
36
effect can be shown only after treatment
with Riedel Cr nitrate and Cr acetate,
which have rather marked cytotoxic
effects when used at very high concentra-
tions. By contrast, in cultures treatedwith
the other Cr3+ compounds, which have
much reduced cytotoxicity, the DNA/cell
is increased, but the RNA content is much
lower than controls. The RNA/DNA ratio
is always dramatically reduced after treat-
ment with all Cr3+ compounds, whereas it
remains almost unchanged after treatment
with Cr6+ (Table I).
The abnormal distribution of optical
densities and radioactivities in the dif-
ferent fractions after incubation with
[3H]-TdRand[3H]-UR (Table II) indicates
that, after treatment with high concentra-
tions ofCr3+, RNA is only partially hydro-
lysed with 10% PCA at 30°C, and is com-
pletelyextracted at 70°C, thus contaminat-
ing the DNA fraction by the usual extrac-
tionprocedure (seeMethods section). RNA
canbe almost completely anddifferentially
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ci)
Chromium (pg /ml)
FIG. 4.-Effects of Cr6+ compounds on CHO
cell survival. Treatment conditions as in
Fig. 3. Symbols for Cr6+ compounds as in
Fig. 1.
extracted at 450C, but at higher tempera-
tures (530C) DNA begins to be hydrolysed
(Table II). Even soluble-pool nucleotides
are not quantitatively extracted with 5%
PCAfrom cultures treated with Cr3+.
We have observed that the extract-
ability of RNA is reduced by Cr3+ when
the cells are treated at the time of seeding
or 24 h later, when they are still in mono-
layer, but is only little affected when
crowded, multilayered cell cultures are
treated (not shown).
5. Mitotic delay and clastogenic effects
Table III shows the percentages of lst-
division metaphases in CHO cells treated
for 30 h with Cr6+ and Cr3+ compounds.
All Cr6+ compounds induce a mitotic delay
proportional to the chromium dose: with
the concentration of 0 5-1 0 ,ug/ml Cr6+
averymarkeddelayofthe cell cycle during
the 1st division is observed. Compared
to the delays induced by Cr6+, the effects
of Cr3+ are much less marked, even if the
cells are exposed to very high Cr concen-
trations (50-150 ,ug/ml).
The mean number of chromosome aber-
rations is significantly increased after
treatment with all Cr6+ compounds, in
TABLE I.-Giant cells induced by Cr6+ and Cr3+ compounds in CHO cell cultures
[Cr]
Treatment* ,g/ml
K2Cr2O 7
Na2Cr2O7
K2CrO4
Na2CrO4
CrO3
CaCrO4
CrCl3
CrK(SO4)2
Cr(NO3)3$
Cr(NO3)3§
Cr(COOCH3)3
0-7
0 9
0-8
0-6
07
0*8
262-0
209-0
312-0
312-0
312-0
Cell growth
(%)
100
4
3
5
6
2
1
61
62
2
83
1
RNAt
45-7
135-3
127-2
113-2
154*3
140-4
130-0
16-5
18-9
95-8
17-5
114-9
DNAt
9-2
20*8
18-5
18*5
29*9
18-6
26-8
17-5
13-3
53-2
1854 54-7
RNA+DNA
54-9
156-1
145-7
131-7
184-2
160-0
156-8
34 0
32*3
149-0
36*0
169-6
RNA/DNA
5*0
6-5
6-9
6-1
5-2
7-1 4.8
0 9
1-4
1-8
0*9
2-1
* CHO cells were seeded and maintained for 5 days in the presence of Cr compounds. Thereafter nucleic
acids were extracted with PCA as detailed in Methods, and the number of cells was determined in parallel
cultures.
t KLg 10-6/cell.
I Riedel De Haen.
§ Merck.
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TABLE II.-Sensitivity of nucleic acids to the hydrolysis with perchloric acid in CHO cell
cultures treated with CrC13 (262 ug Cr3+/ml)
3H-
labelled
Treatment precursor*
TdR
UR
I TdR
UR
CrC13 TdR
|TdR
UR
Temperature
(°C) of
RNA
hydrolysis
37
37
37
37
45
45
53
53
Optical density
A_
Nucleotide
pool
0-19
0-17
0-08
009
0 09
0-10
0-08
0-08
RNA
0-68
0*60
0-46
0-48
0-63
0-65
0*75
0 79
DNA
0*23
0-22
0 44
0 45
0-22
0.22
012
0-14
% Radioactivity
RNA/
DNA
3.0
2-7
1.0
1-0
2-9
3*0
6*3
5-6
RNA
1.0
96-9
1-1
60*1
1*0
95*1
37-7
99-6
DNA
99.0
3-1
98-9
39.9
99.0
4.9
62*3
0 4
* The cultures were incubated for 1 h with [3H]-TdR or [3H]-UR and then treated for 2 h with CrCl3.
Thereafter, soluble nucleotides, RNA and DNA were extracted with PCA as detailed in Methods. RNA
extraction was also performed by hydrolysis at 45°C or 53°C, instead of at 37°C.
proportion to concentration (Tab. III);
the increase is about 10-fold after exposure
to 1.0 ,ug/ml Cr6+, as sodium dichromate.
On the other hand the frequency of
chromosome aberrations is doubled after
treatment with up to 150 ,ug/ml Cr3+, and
it is trebled by exposure to 50 tg/ml Cr3+
only in the case of Riedel Cr nitrate. A
detailed analysis of chromosome aber-
rations shows that single chromatid gaps,
breaks and interchanges prevail, the fre-
quencies of which increase in proportion
to the concentration of Cr. Dicentric
chromosomes, isochromatid breaks,
chromosome and chromatid rings are
also induced, but their frequency does not
increase linearly with the Cr concentra-
tion.
Table IV shows that the frequencies of
SCE in 2nd-division metaphases are sig-
nificantly increased after treatment with
all Cr6+ compounds and with Riedel Cr
nitrate, but not with the other Cr3+
compounds. However the increase of SCE
frequency after treatment with Cr6+ is
much lower than that induced by mito-
mycin C, which was used as a positive
control for the response of our cell
system to the induction of chromosome
damage.
DISCUSSION
The increased incidence oflung tumours
in workers exposed to Cr is generally
attributed to the carcinogenic effect of its
hexavalent oxidation form (Browning,
1969; Furst & Haro, 1969; IARC, 1973).
Several Cr6+ compounds, such as Ca, Zn,
Sr and Pb chromates, chromic trioxide
and mixtures of K dichromate and Na
chromate, are capable ofinducing tumours
in experimental animals (Hueper, 1961;
Roe & Carter, 1969; IARC, 1973; Maltoni,
1977). However, even some Cr3+ com-
pounds, such as Cr oxide as pure salt
(Dvizhkov & Federova, 1967) or as residue
of roasted chromite ore (Hueper, 1958;
Payne, 1960), chromic acetate (Hueper,
1961) and chromic sulphates such as
neochromium and chrome alum (Maltoni,
1977) have been shown to be carcinogenic,
although with a lower frequency and with
a longer incubation period than Cr6+
compounds.
For Cr6+ compounds, a very good cor-
relation has been found between their
carcinogenic action and the cytogenetic
effects induced in different biological
systems: infidelity of DNA replication in
vitro (Sirover & Loeb, 1976), interactions
with purified nucleic acids (Tamino, 1977),
point mutations in bacteria (Venitt &
Levy, 1974; Nishioka, 1975; Petrilli &
De Flora, 1977) and yeasts (Bonatti et al.,
1976), chromosome aberrations (Tsuda &
Kato, 1977; Majone & Levis, 1979; Majone
& Rensi, 1979) and stimulation of DNA
repair synthesis (Raffetto et al., 1977) in
mammalian cell cultures, and in vitro cell
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TABLE IV.-Sister chromatid exchanges induced by Cr6+ and Cr3+ compounds in CHO
cell cultures
2nd divn
metaphases
counted
84
85
20
67
27
70
13
21
13
66
61
59
58
49
46
48
42
20
Chromosomes
per
metaphase
18-66 + 0-14
19-74+ 0-16
17-20 + 0-86
18-78 + 0-30
17-67 + 057
19-28 + 0-21
18-08 + 0-25
17-90 + 0-51
18-38 + 0-45
18-85 + 0-28
19-34 + 0-26
19-20 + 0-25
18-45 + 0-35
19-75 + 0-49
18-19 + 0-30
19-70 + 0-83
19-44 + 068
20-60 + 0-38
Sister chromatid exchanges t for
________~- A SCE/
per
metaphase
6-45 + 024
11-25+0-31
11-85+0-78
10-40 + 040
10-78 + 0-36
9-80 + 0-31
10-62 + 0-33
11-00+0 44
10-61 + 0-33
5 47 + 0 33
6-81 + 0-32
9-98 + 0-41
6-19+0-38
6-37+0 50
7-02 + 037
6-51 + 0-32
6-41 + 0-29
42-40+ 1-39
per
chromosome
0 34+0-01
0*57 + 0-02
0*70 + 0-04
0-55 + 0-02
0-54+0-02
0.50 + 0-01
059 + 0-20
0-61 + 0-02
0-58 + 0-22
0-29 + 0-02
0-35 + 0-13
0-52 + 0-02
0-34 + 0-02
0 33 + 003
0-38 + 0-02
0-34 + 0-02
0 34 + 0-02
2-06 + 0-08
* Riedel De Haen. t Merck. 1 0-03 ,ug/ml (10-7M).
transformation (Fradkin et al., 1975;
Tsuda & Kato, 1977). Such a correlation
is on the contrary still obscure when the
cytogenetic effects of Cr3+ compounds are
examined. As a matter of fact they have
always given negative results when tested
for the induction of point mutations in
bacteria (Venitt & Levy, 1974; Nishioka,
1975; Petrilli & De Flora, 1977), and for
the stimulation ofDNA repair synthesis in
mammalian cells (Raffetto et al., 1977).
Furthermore, addition of a strong oxidiz-
ing agent to several inactive Cr3+ com-
pounds resulted in a dose-effect mutagenic
response with the Salmonella test system,
due to oxidation to the active hexavalent
state (Petrilli & De Flora, 1978b), whereas
incubation of mutagenic Cr6+ compounds
with reducing agents or metabolic sys-
tems, such as liver microsomal fractions
and erythrocyte lysates, caused complete
loss of mutagenicity, which was ascribed
to reduction of the metal to the inactive
trivalent form through a simple oxido-
reductive reaction (Petrilli & De Flora,
1978a). Also, the clastogenic action of
Cr6+ on cultured hamster cells is sup-
pressed by the addition of a reducing
agent (Tsuda & Kato, 1977). However,
Cr3+ compounds have been shown to
interact with purified nucleic acids (Eisin-
ger et al., 1962; Huff et al., 1964; Danchin,
1975; Tamino, 1977) to produce chromo-
some aberrations in plant (Glass, 1956)
and animal cell cultures (Raffetto et al.,
1977; Majone & Rensi, 1979) and to
induce cell transformation in vitro (Raf-
fetto et al., 1977). Furthermore, the altera-
tion of DNA replication fidelity seen in
the presence of CrCl2 (Sirover & Loeb,
1976) could be attributed to Cr3+, because
divalent Cr compounds are extremely
unstable unless carefully protected from
oxidation to Cr3+, which takes place very
easily in air, water and biological systems
(Mertz, 1969).
Very marked differences of cytotoxic
(Levis et at., 1978a, b; Luciani et al., 1979)
and clastogenic (Majone & Rensi, 1979)
activity between Cr6+ (as potassium di-
[Cr]
Ktg/ml
0-3 { 0
03
0-25
0-25
f 0-1
L 0-25
{ 50
50.0
50*0
{ 500
150-0
150-0
f 5*0
120-0
Treatment
K2Cr2O 7
Na2Cr2O 7
K2CrO4
Na2CrO4
CrO3
CrC13
Cr(NO3)3*
Cr(NO3)3t
KCr(804)2
Cr(COOCH3)3
Mitomycin Ct
meta-
phase
12-19
8-64
19-67
9 09
4.49
5-58
4-55
5-62
0*03
0-41
2-40
0*40
0-25
0-65
0-16
0-10
29-62
p
< 0-001
< 0-001
< 0-001
< 0-001
< 0-001
< 0-001
< 0-001
< 0-001
>0*7
> 0 7
< 0-001
> 0 6
> 0*7
> 0*5
> 0 7
> 0 7
< 0-001
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chromate) and Cr3+ (as CrC13) have been
seen in different mammalian cell lines. The
present data on the cytotoxic action of
11 water-soluble Cr compounds show that
all Cr6+ compounds inhibit growth of
BHK cells and reduce survival of CHO
cells to levels comparable to those ob-
tained only after exposure to Cr3+ con-
centrations 100-1000-fold higher.
It must be noted that survival and
growth-inhibition curves obtained with
the different Cr6+ compounds are almost
overlapping when cell inactivation is
referred to the actual concentrations of
Cr6+ determined by DFCA in the treat-
ment solutions, indicating that the cyto-
toxic effect is most probably due to the
presence of the oxidized metal. On the
other hand, marked differences of cyto-
toxic activity are noticeable among Cr3+
compounds. In particular Riedel Cr nitrate
is comparatively more active than the
same salt manufactured by Merck, though
the presence of a 2 x 10-3 contamination
with Cr6+ in the former compound accoun-
tedfor its cytotoxic effect. Crsulphate and
acetate, though not containing detectable
amounts of Cr6+, are more toxic than
CrC13 and Merck Cr nitrate. Even such
small cytotoxic action is therefore related
to properties of these compounds other
than the presence of Cr, whatever its
oxidation state.
CHO survival curves to the different
Cr6+ compounds are very similar to those
obtained with BHK cells treated with
K2Cr2O7 (Levis et al., 1978a); namely,
they are classical multi-hit curves with an
initial, rather pronounced shoulder fol-
lowed by an exponential portion.
Giant cells were seen after treatment
of mammalian cell cultures with Cr6+
(Majone, 1977) and are the consequence of
the blockage of the cell cycle without a
sudden inhibition of macromolecular syn-
theses, in particular of RNA and protein
syntheses (Levis et at., 1978b). In the
present experiments almost pure giant-
cell populations are obtained with the rise
of DNA and RNA per cell, provided that
treatments are made with Cr concentra-
tions that reduce cell growth and survival
to very low levels. This is not a specific
effect of Cr6+, as it is induced also by
the relatively toxic Cr3+ compounds
Riedel chromium nitrate and chromium
acetate.
A specific effect of Cr3+ compounds is
the resistance of nucleic acids, especially
of RNA, to hydrolysis with PCA, which
was attributed to the stabilization of
nucleic acid tertiary structure by Cr3+
(Levis et al., 1978a) in accordance with the
modifications of the physico-chemical
properties of purified RNA seen in the
presence of CrC13 (Huff et al., 1964;
Tamino, 1977). Such interpretation seems
very unlikely on the basis of the present
data, as the reduced extractability ofRNA
is found even after treatment with Cr3+
concentrations at which cell growth and
survival are only partially affected. Also
the extractability of soluble pool nucleo-
tides is altered, which is due to dehydra-
tion by PCA and not to its hydrolytic
action. Moreover, such alterations are
noticeable when monolayer cultures are
treated, but are much less marked when
crowded, multilayer cultures are exposed.
Therefore, the alteration of cell membrane
by Cr3+, or tanning ofextracellular matrix
proteins, would moreprobablybeinvolved,
which could affect only the superficial
layer of cells and give rise to a reduced
permeabilitytoPCAandareducedextract-
ability of nucleotides and nucleic acids at
low temperatures.
The present data on the clastogenic
effects of Cr show that both Cr6+ and
Cr3+ are able to induce chromosome
aberrations, whereas Cr3+ is absolutely
incapable of inducing SCE, only Cr6+
being active. As we have already noted
(Majone & Levis, 1979), in spite of the
sensitivity of CHO cells to the induction
of SCE by mitomycin C, the frequency of
SCE hardly doubles after exposure to
Cr6+ compounds.
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